| Patient | Sonny Liston |
|---|---|
| Date of birth | 1932-05-08 |
| Identifiers | MRN HR-BX007-SYN-TD; SSN (made up) 000-07-8853 |
| Document date | 1969-06-23 |
| Author | Malcolm Achebe-Whitford, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week review of high blood pressure, seen the same day by cardiology. [S]
Sonny Liston returns two weeks after intake and is seen the same day by Dr. Lindqvist-Owusu. He wore the ambulatory blood pressure monitor for 24 hours last week, including a training session, and had an echocardiogram this morning. His intake blood tests were normal apart from a mildly raised AST and GGT, which were explained to him in plain words as signs that alcohol is affecting his liver. He has cut his drinking from about 25 drinks a week to about 18 by keeping a tally of marks on a card, but found the weekends hard. He feels well and has no headaches, chest pain, breathlessness or palpitations. He wants to know whether he can fight again this year. No thoughts of suicide. [S]
| Element | Detail |
|---|---|
| Ambulatory monitoring | Daytime 146/94, nighttime 132/84, 24-hour 142/91 mmHg |
| Echocardiogram | Mild concentric LVH (12 mm); ejection fraction 60 percent; normal diastolic function |
| Drinking | About 18 drinks a week, from about 25 |
| Urine albumin | 18 mg/g, normal |
| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, palpitations, fainting or ankle swelling |
| Respiratory | Negative | No breathlessness beyond what he expects in hard sparring |
| Neurological | Negative | No headaches, vision change or weakness |
| Psychiatric | Negative | Mood all right; no thoughts of suicide |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Amlodipine 5 mg and valsartan 160 mg combined oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-06-23 to 1969-07-21 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-06-23 | Body height | 185 | cm | S |
| 1969-06-23 | Body weight | 98.6 | kg | S |
| 1969-06-23 | Body mass index (BMI) [Ratio] | 28.8 | kg/m2 | S |
| 1969-06-23 | Systolic blood pressure | 148 | mm[Hg] | S |
| 1969-06-23 | Diastolic blood pressure | 96 | mm[Hg] | S |
| 1969-06-23 | Heart rate | 56 | /min | S |
| 1969-06-23 | Respiratory rate | 14 | /min | S |
| 1969-06-23 | Body temperature | 36.6 | Cel | S |
| 1969-06-23 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
Vital signs recorded on 1969-06-23; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 148/96 mmHg (average of two, large cuff); pulse 56; weight 98.6 kg |
| Cardiovascular | Regular slow rhythm; no murmur, gallop or edema; foot pulses normal |
| Respiratory | Clear to auscultation |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| High blood pressure readings at a first visit (154/98 mmHg, average of two readings with a large cuff), without a diagnosis of hypertension; out-of-office confirmation needed | resolved | confirmed | R03.0 | S — Synthetic presenting finding; resolved into the diagnosis at the consultation visit when ambulatory monitoring confirmed hypertension. |
| Hypertension, stage 2, confirmed by 24-hour ambulatory monitoring (daytime average 146/94 mmHg, nighttime 132/84 mmHg), with mild concentric left ventricular hypertrophy on echocardiography and normal kidney function and urine albumin | active | confirmed | I10 | S — Synthetic modern diagnosis; no hypertension is documented in his life. |
| Alcohol use disorder, moderate (four DSM-5-TR criteria: drinking more than intended, unsuccessful efforts to cut down, craving, and continued drinking despite its effect on his training, blood pressure and liver tests); AUDIT 16 | active | confirmed | F10.20 | S — Synthetic modern diagnosis by interview, anchored to the description of heavy drinking; not a historical diagnosis. |
| Personal history of physical abuse in childhood (beaten regularly by his father), with heavy field work from the age of eight | active | confirmed | Z62.810 | S — Synthetic coding of the documented childhood history; physical abuse only. |
| Does not read or write (no schooling as a child); prefers spoken explanations, pictures and demonstrations | active | confirmed | Z55.0 | S — Synthetic coding of the documented literacy, recorded so that care is adapted. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Office blood pressure (seated, large cuff, average of two readings), weight and BMI, heart sounds | Every visit | Completed today | 148/96 mmHg; weight 98.6 kg; no gallop |
| Examination | Out-of-office blood pressure (ambulatory or home monitoring) | At diagnosis and after each treatment change | Completed today | 24-hour ambulatory monitoring last week: daytime 146/94, nighttime 132/84 mmHg; confirms hypertension |
| Laboratory | Potassium, creatinine and eGFR | Baseline; two to four weeks after starting an ARB; then every six months on an ARB | Ordered | Baseline potassium 4.1 mmol/L and creatinine 1.1 mg/dL (eGFR 89) at intake; recheck at four weeks after starting valsartan |
| Laboratory | Lipids, glucose or A1c, urine albumin-to-creatinine ratio, TSH | At diagnosis, then yearly (TSH at diagnosis) | Up to date | At intake: LDL 122, HDL 58 mg/dL; A1c 5.4%; urine albumin-to-creatinine ratio 18 mg/g; TSH 1.6 |
| Imaging | 12-lead ECG | Baseline at diagnosis | Up to date | At intake: sinus bradycardia 56; LVH voltage criteria without repolarization change |
| Imaging | Echocardiogram | At diagnosis for stage 2 hypertension or suspected LVH; repeat as indicated | Completed today | Mild concentric LVH (12 mm); ejection fraction 60 percent; normal diastolic function and aortic root |
| Examination | Fundoscopic examination | Yearly | Due | At the preventive visit |
| Survey | Cardiovascular risk estimate | Yearly | Due | At the preventive visit; the pooled cohort equations apply only from 40 |
| Medication safety | Antihypertensive tolerance (ankle edema, dizziness) and adherence by teach-back | Each follow-up and each dose change | Not indicated | No antihypertensive until today; teach-back of the new tablet done with the picture card |
| Referral | Fitness to compete (AHA/ACC athlete statement) | At diagnosis and before returning to competition | Completed today | Cardiology: no competition until controlled; then clearance with a repeat check |
| Survey | Drinking (AUDIT-C, drinks per week, drinking days) | Every follow-up during treatment; full AUDIT at about four months | Up to date | AUDIT 16 at intake; about 18 drinks a week now by his tally; next AUDIT-C at four weeks |
| Laboratory | Liver tests (AST, ALT, GGT) | Baseline; about two months after starting naltrexone or cutting down; then as indicated | Up to date | At intake: AST 46, ALT 38, GGT 88 U/L; recheck in about two months |
| Survey | Suicide-risk review (structured questions) and safety plan | Every visit | Completed today | No thoughts of suicide; safety plan card reviewed |
| Self-management | Health literacy: teach-back, picture card, read-aloud consent, voice reminders | Every visit | Completed today | Plan explained in two key points; he repeated them back correctly; consent for the echocardiogram read aloud |
Goal progress:
Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); Hypertension in Adults: Screening (2021); CMID: Clinical Monitoring Intelligence Database, hypertension and depression monographs (2026); Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 6: Hypertension (Black HR, et al.) (2015); The Healthcare Professional's Core Resource on Alcohol (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); AHRQ Health Literacy Universal Precautions Toolkit, 3rd Edition (2024)
Follow-up: Four-week review with potassium, creatinine and AUDIT-C. Home readings each morning by photo message. Call 988 or the clinic at any time if thoughts of suicide arise. Next scheduled visit 1969-07-21: four-week review: blood pressure on treatment, potassium and creatinine, drinking, and medicine teach-back. [S]